Rituximab regulates the expression of the Raf kinase inhibitor protein via NF-κB in renal tissue of rats with diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Genetics and Molecular Research

• Publication date

  2013-08-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4238/2013.August.16.1PMID 24065653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry

  2012cited by this paper
• Rituximab in the treatment of refractory lupus nephritis with vasculitis.

  2012cited by this paper
• Amlodipine Reduces Inflammation despite Promoting Albuminuria in the Streptozotocin-Induced Diabetic Rat

  2012influential reference
• Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy.

  2012influential reference
• Prognostic value of RKIP and p-ERK in gastric cancer

  2012cited by this paper
• B lymphocyte-typing for prediction of clinical response to rituximab

  2012cited by this paper
• New Experimental Models of Diabetic Nephropathy in Mice Models of Type 2 Diabetes: Efforts to Replicate Human Nephropathy

  2012cited by this paper
• Cytokines in diabetic nephropathy.

  2012cited by this paper
• Raf family kinases: old dogs have learned new tricks.

  2011cited by this paper
• Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?

  2010cited by this paper
• Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

  2010cited by this paper
• Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.

  2009cited by this paper
• Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7

  2009cited by this paper
• Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target

  2008cited by this paper
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

  2007cited by this paper
• RKIP does not contribute to MAP kinase pathway silencing in the Merkel Cell Carcinoma cell line UISO

  2007cited by this paper
• The protective effect and its mechanism of atorvastatin on diabetic nephropathy in diabetic rats

  2006influential reference
• Inhibition of the Raf–MEK1/2–ERK1/2 Signaling Pathway, Bcl-xL Down-Regulation, and Chemosensitization of Non-Hodgkin’s Lymphoma B Cells by Rituximab

  2004cited by this paper
• The role of Raf kinase inhibitor protein (RKIP) in health and disease.

  2004cited by this paper
• Practical bioinformatics for proteomics.

  2004cited by this paper
• Transcriptional Regulation of Type I Diabetes by NF-κB 1

  2003cited by this paper
• Transcriptional regulation of type I diabetes by NF-kappa B.

  2003cited by this paper
• Activation of Raf-1 Signaling by Protein Kinase C through a Mechanism Involving Raf Kinase Inhibitory Protein*

  2003cited by this paper
• Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

  2003cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• NF-κB in cancer: from innocent bystander to major culprit

  2002cited by this paper
• Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

  2001cited by this paper
• Raf Kinase Inhibitor Protein Interacts with NF-κB-Inducing Kinase and TAK1 and Inhibits NF-κB Activation

  2001cited by this paper

• Opposing roles of YY1 and RKIP in cancer progression and therapy resistance.

  2025cites this paper
• Unraveling the RKIP–YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders

  2025cites this paper
• Melatonin alleviates arsenic‐induced liver injury by regulating protein RKIP and enhancing antioxidant defencse mechanisms

  2024cites this paper
• AR/RKIP pathway mediates the inhibitory effects of icariin on renal fibrosis and endothelial-to-mesenchymal transition in type 2 diabetic nephropathy.

  2023cites this paper
• Identification of Markers for Diagnosis and Treatment of Diabetic Kidney Disease Based on the Ferroptosis and Immune

  2022cites this paper
• Sex-Specific B Cell and Anti-Myelin Autoantibody Response After Peripheral Nerve Injury

  2022cites this paper
• Protective Effect of Raf-1 Kinase Inhibitory Protein on Diabetic Retinal Neurodegeneration through P38-MAPK Pathway

  2021cites this paper
• Liraglutide inhibits the progression of prediabetes in rats by reducing Raf-1 kinase inhibitor protein

  2021cites this paper
• RKIP a master of regulatory pathways: Perspectives

  2020cites this paper
• RKIP in human diseases and its potential as a prognostic indicator and therapeutic target

  2020cites this paper
• The role of Raf kinase inhibitory protein in inflammation

  2020cites this paper
• B cell Activity and anti-MBP Autoantibody Response to Peripheral Nerve Injury is Sexually Dimorphic

  2020cites this paper
• Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling

  2019cites this paper
• RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer

  2019cites this paper
• RKIP negatively regulates the glucose induced angiogenesis and endothelial-mesenchymal transition in retinal endothelial cells.

  2019cites this paper
• PEBP1/RKIP: from multiple functions to a common role in cellular processes

  2018cites this paper
• Rituximab in Minimal Change Disease

  2017cites this paper
• RKIP inhibits the proliferation and migration of human retinal pigment epithelial cells by suppressing the MAPK pathway

  2016cites this paper
• Understanding perspectives of signalling mechanisms regulating PEBP1 function

  2016cites this paper
• Short RKIP in Inflammatory Signaling Interactions of RKIP with Inflammatory Signaling Pathways

  2014cites this paper
• Interactions of RKIP with inflammatory signaling pathways.

  2014cites this paper